Literature DB >> 30284075

Effect of serum uric acid on cognition in patients with idiopathic REM sleep behavior disorder.

Xudong Li1,2, Shuhong Jia3, Zhi Zhou4, Yi Jin3, Xiangfei Zhang3, Chunlei Hou3, Wenjing Zheng3, Pei Rong3, Jinsong Jiao3.   

Abstract

Idiopathic rapid eye movement sleep behavior disorder (iRBD) likely represents the prodromal stage of synucleinopathy. The present study investigated how levels of serum uric acid (UA) affect cognition and motor function in patients with iRBD. A total of 42 patients with iRBD and 45 healthy controls were included. All participants were given cognitive tests and motor assessments. Serum UA concentrations were measured. The patients were further divided into two groups (high or low UA) according to serum UA level. The level of serum UA was similar between the patients with iRBD and the healthy controls, whereas the patients showed impaired executive, memory, and visuospatial functions. The patients with low UA levels had longer durations of RBD. Lower scores involving attention, executive function, and language domain were also found in the patients with low UA, whereas the scores of the patients with high UA were similar to those of the healthy controls. Regarding memory domain, the low UA group had worse scores than the healthy controls, whereas the scores of high UA group fell between those of the low UA group and the healthy controls. Motor function was not affected in any of the groups. UA affects cognitive function but not motor function in patients with iRBD, which could contribute to its antioxidant and neuroprotective roles.

Entities:  

Keywords:  Cognition; Idiopathic REM sleep behavior disorder; Synucleinopathy; Uric acid

Mesh:

Substances:

Year:  2018        PMID: 30284075     DOI: 10.1007/s00702-018-1935-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  41 in total

Review 1.  MDS research criteria for prodromal Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

2.  Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.

Authors:  Alex Iranzo; Francesc Valldeoriola; Francisco Lomeña; José Luis Molinuevo; Mónica Serradell; Manel Salamero; Albert Cot; Domènec Ros; Javier Pavía; Joan Santamaria; Eduardo Tolosa
Journal:  Lancet Neurol       Date:  2011-07-28       Impact factor: 44.182

3.  Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder.

Authors:  Ping Wu; Huan Yu; Shichun Peng; Yves Dauvilliers; Jian Wang; Jingjie Ge; Huiwei Zhang; David Eidelberg; Yilong Ma; Chuantao Zuo
Journal:  Brain       Date:  2014-10-22       Impact factor: 13.501

4.  The Purdue Pegboard Test: normative data for people aged 60 and over.

Authors:  J Desrosiers; R Hébert; G Bravo; E Dutil
Journal:  Disabil Rehabil       Date:  1995-07       Impact factor: 3.033

5.  Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder.

Authors:  Maria Livia Fantini; Elena Farini; Paola Ortelli; Marco Zucconi; Mauro Manconi; Stefano Cappa; Luigi Ferini-Strambi
Journal:  Sleep       Date:  2011-05-01       Impact factor: 5.849

6.  REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.

Authors:  D O Claassen; K A Josephs; J E Ahlskog; M H Silber; M Tippmann-Peikert; B F Boeve
Journal:  Neurology       Date:  2010-07-28       Impact factor: 9.910

7.  Plasma urate in REM sleep behavior disorder.

Authors:  Reinaldo Uribe-San Martín; Pablo Venegas Francke; Felipe López Illanes; Alex Jones Gazmuri; Julio Salazar Rivera; Jaime Godoy Ferńndez; Julia Santín Martínez; Carlos Juri
Journal:  Mov Disord       Date:  2013-03-27       Impact factor: 10.338

8.  Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder.

Authors:  Timothy M Ellmore; Richard J Castriotta; Katie L Hendley; Brian M Aalbers; Erin Furr-Stimming; Ashley J Hood; Jessika Suescun; Michelle R Beurlot; Roy T Hendley; Mya C Schiess
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

9.  Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.

Authors:  Jean-François Gagnon; Mélanie Vendette; Ronald B Postuma; Catherine Desjardins; Jessica Massicotte-Marquez; Michel Panisset; Jacques Montplaisir
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

Review 10.  Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis.

Authors:  Aamir A Khan; Terence J Quinn; Jonathan Hewitt; Yuhua Fan; Jesse Dawson
Journal:  Age (Dordr)       Date:  2016-01-28
View more
  2 in total

1.  Uric Acid Enhances Neurogenesis in a Parkinsonian Model by Remodeling Mitochondria.

Authors:  Ji Eun Lee; Yu Jin Shin; Yi Seul Kim; Ha Na Kim; Dong Yeol Kim; Seok Jong Chung; Han Soo Yoo; Jin Young Shin; Phil Hyu Lee
Journal:  Front Aging Neurosci       Date:  2022-06-02       Impact factor: 5.702

2.  Plasma urate concentrations and possible REM sleep behavior disorder.

Authors:  Yun Shen; Junjuan Li; Michael Schwarzschild; Milena Pavlova; Songbin He; Alberto Ascherio; Shouling Wu; Liufu Cui; Xiang Gao
Journal:  Ann Clin Transl Neurol       Date:  2019-11-12       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.